Bell Investment Advisors’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.23K Buy
39
+21
+117% +$662 ﹤0.01% 1490
2025
Q4
$531 Buy
+18
New +$500 ﹤0.01% 1730
2025
Q3
Sell
-41
Closed -$984 1953
2025
Q2
$984 Hold
41
﹤0.01% 1591
2025
Q1
$939 Sell
41
-20
-33% -$483 ﹤0.01% 1567
2024
Q4
$1.54K Hold
61
﹤0.01% 1425
2024
Q3
$1.52K Hold
61
﹤0.01% 1454
2024
Q2
$1.81K Sell
61
-17
-22% -$472 ﹤0.01% 1395
2024
Q1
$2.35K Hold
78
﹤0.01% 1286
2023
Q4
$2.23K Buy
78
+20
+34% +$587 ﹤0.01% 1283
2023
Q3
$2.15K Hold
58
﹤0.01% 1237
2023
Q2
$2.26K Sell
58
-16
-22% -$627 ﹤0.01% 1234
2023
Q1
$2.7K Hold
74
﹤0.01% 1098
2022
Q4
$2.28K Buy
+74
New +$2.3K ﹤0.01% 1217

Other funds holding RTO

Bell Investment Advisors's RTO Position: Q1 2026 in Review

Bell Investment Advisors increased its Rentokil (RTO) stake by 117% in Q1 2026, buying an estimated $662 and bringing the position to 39 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #1490.

Bell Investment Advisors first reported a position in RTO in Q4 2022 and has held it in 13 quarters since. The position peaked at $2.7K in Q1 2023. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Bell Investment Advisors held 39 shares of Rentokil worth $1.23K as of Q1 2026.
  • Bell Investment Advisors bought 21 Rentokil shares in Q1 2026, an estimated $662.
  • Rentokil made up ﹤0.01% of Bell Investment Advisors's portfolio in Q1 2026, its #1490 holding.
  • Bell Investment Advisors first reported a position in Rentokil in Q4 2022 and has held it in 13 quarters since.
  • Bell Investment Advisors's Rentokil position peaked at $2.7K in Q1 2023.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Bell Investment Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.